lunes, 3 de septiembre de 2018

Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations

Main|Search|PHGKB

rare diseases with DNA

From National Institutes of Health Web Sites


No hay comentarios:

Publicar un comentario